NextCure Inc. (NXTC) PT Lowered to $4 at Roth Capital
Tweet
Share
E-mailGet Alerts NXTC Hot Sheet
Price: $7.79 +15.75%
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 18 | New: 6
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 18 | New: 6
Join SI Premium – FREE
Roth Capital analyst Tony Butler lowered the price target on NextCure Inc. (NASDAQ: NXTC) to $4.00 (from $6.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Brainsway (BWAY) PT Raised to $20 at BTIG
- Lemon Tree Hotels (LEMONTRE:IN) PT Raised to INR180 at Macquarie
- Tokyo Tatemono Co Ltd (8804:JP) PT Raised to JPY4,480 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
